Meeting
Abstract Number: 285
SHM Converge 2023
Background: Asymptomatic bacteriuria (ASB), the presence of bacteria in urine without signs or symptoms of a urinary tract infection, is a common finding. The current recommendation by the Infectious Diseases Society of America is against screening for and treating ASB in patients undergoing non-urologic surgeries, due to the lack of demonstrable benefit in reducing the […]
Abstract Number: 363
SHM Converge 2023
Background: Clostroidiodes difficile (CD) is the most prevalent hospital-acquired infection in the United States, accounting for approximately 224,000 infections with 13,000 deaths and over 1 billion dollars spent in 2017, according to the Centers for Disease Control and Prevention (CDC). Clostroidiodes difficile accounts for 10-20% of diarrhea in the setting of recent antibiotics exposure.In St […]
Abstract Number: 387
SHM Converge 2023
Background: US healthcare costs are exorbitant and excessive lab utilization contributes significantly1. Daily labs (DLs) are often over-ordered for inpatients.2 This leads to increased costs, iatrogenic anemia, patient discomfort and limits phlebotomy resources 3. The Choosing Wisely® campaign recommends against checking DL in patients who have clinical and lab stability5. Previous quality improvement initiatives have […]